Among the first 105 consecutively enrolled patients with RET fusion-positive NSCLC who were previously treated with at least platinum-based chemotherapy, 58 had received prior ICI therapy and 47 had no prior ICI therapy (Supplementary Table 1). Here, RET is linked to non-small cell lung carcinoma.